c-Ets1 inhibits the interaction of NF-kappa B and CREB, and downregulates IL-1 beta-induced MUC5AC overproduction during airway inflammation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, K. S. | - |
dc.contributor.author | Yoon, J-H | - |
dc.contributor.author | Kim, K. S. | - |
dc.contributor.author | Ahn, D. W. | - |
dc.date.available | 2019-05-29T07:39:29Z | - |
dc.date.issued | 2012-03 | - |
dc.identifier.issn | 1933-0219 | - |
dc.identifier.issn | 1935-3456 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/20457 | - |
dc.description.abstract | Mucin hypersecretion is frequently observed in many inflammatory diseases of the human respiratory tract. As mucin hypersecretion refers to uncontrolled mucin expression and secretion during inflammation, studies examining the negative control mechanisms of mucin hypersecretion are vital in developing novel therapeutic medications. We hypothesized that the c-Ets1 induced by interleukin (IL)-1 beta would decrease MUC5AC overproduction by inhibiting the interaction of NF-kappa B with cAMP response element-binding protein (CREB) in vivo. Stimulation with IL-1 beta caused the direct binding of NF-kappa B and CREB to the MUC5AC promoter, thus increasing MUC5AC gene expression. However, IL-1 beta-induced MUC5AC messenger RNA levels were surprizingly downregulated by c-Ets1 (located -938 to -930). Interestingly, c-Ets1 also suppressed IL-1 beta-induced MUC5AC gene expression in vitro and in vivo by disrupting the interaction of NF-kappa B with CREB on the MUC5AC promoter. In addition, c-Ets1 also inhibited significant morphologic changes and inflammatory cell infiltration after IL-1 beta exposure in mouse lungs infected with either wild-type or shRNA-c-Ets1. Moreover, reactive oxygen species produced by NOX4 increased c-Ets1 gene expression and MUC5AC gene expression in alveolar macrophages from bronchoalveolar lavage fluid. These results suggest a molecular paradigm for the establishment of a novel mechanism underlying the negative regulation of mucin overproduction, thus enhancing our understanding of airway inflammation. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.title | c-Ets1 inhibits the interaction of NF-kappa B and CREB, and downregulates IL-1 beta-induced MUC5AC overproduction during airway inflammation | - |
dc.type | Article | - |
dc.identifier.doi | 10.1038/mi.2011.67 | - |
dc.identifier.bibliographicCitation | MUCOSAL IMMUNOLOGY, v.5, no.2, pp 207 - 215 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000300508700010 | - |
dc.identifier.scopusid | 2-s2.0-84863148592 | - |
dc.citation.endPage | 215 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 207 | - |
dc.citation.title | MUCOSAL IMMUNOLOGY | - |
dc.citation.volume | 5 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordPlus | ELEMENT-BINDING PROTEIN | - |
dc.subject.keywordPlus | MUC8 GENE-EXPRESSION | - |
dc.subject.keywordPlus | EPITHELIAL-CELLS | - |
dc.subject.keywordPlus | REACTIVE OXYGEN | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR | - |
dc.subject.keywordPlus | NAD(P)H OXIDASE | - |
dc.subject.keywordPlus | ANGIOTENSIN-II | - |
dc.subject.keywordPlus | NADPH OXIDASE | - |
dc.subject.keywordPlus | ETS-1 | - |
dc.subject.keywordPlus | INTERLEUKIN-1-BETA | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.